BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 35411033)

  • 1. Role of adenosine deaminase in prostate cancer progression.
    Charles C; Lloyd SM; Piyarathna DWB; Gohlke J; Rasaily U; Putluri V; Simons BW; Zaslavsky A; Nallandhighal S; Michailidis G; Palanisamy N; Navone N; Jones JA; Ittmann MM; Putluri N; Rowley DR; Salami SS; Palapattu GS; Sreekumar A
    Am J Clin Exp Urol; 2023; 11(6):594-612. PubMed ID: 38148936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cDNA cloning and amino acid sequence of human mitochondrial delta 3 delta 2-enoyl-CoA isomerase: comparison of the human enzyme with its rat counterpart, mitochondrial short-chain isomerase.
    Kilponen JM; Häyrinen HM; Rehn M; Hiltunen JK
    Biochem J; 1994 May; 300 ( Pt 1)(Pt 1):1-5. PubMed ID: 8198519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mitochondrial 3,2-trans-enoyl-CoA isomerase (DCI): gene structure and localization to chromosome 16p13.3.
    Janssen U; Fink T; Lichter P; Stoffel W
    Genomics; 1994 Sep; 23(1):223-8. PubMed ID: 7829074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into lipid metabolism and prostate cancer (Review).
    Zhang Z; Wang W; Kong P; Feng K; Liu C; Sun T; Sang Y; Duan X; Tao Z; Liu W
    Int J Oncol; 2023 Jun; 62(6):. PubMed ID: 37203395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis landscape in prostate cancer from molecular and metabolic perspective.
    Liang J; Liao Y; Wang P; Yang K; Wang Y; Wang K; Zhong B; Zhou D; Cao Q; Li J; Zhao Y; Jiang N
    Cell Death Discov; 2023 Apr; 9(1):128. PubMed ID: 37061523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reperfusion after hypoxia-ischemia exacerbates brain injury with compensatory activation of the anti- ferroptosis system: based on a novel rat model.
    Zhang TL; Zhang ZW; Lin W; Lin XR; Lin KX; Fang MC; Zhu JH; Guo XL; Lin ZL
    Neural Regen Res; 2023 Oct; 18(10):2229-2236. PubMed ID: 37056142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer.
    Lasorsa F; di Meo NA; Rutigliano M; Ferro M; Terracciano D; Tataru OS; Battaglia M; Ditonno P; Lucarelli G
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinventing the human tuberculosis (TB) granuloma: Learning from the cancer field.
    Ashenafi S; Brighenti S
    Front Immunol; 2022; 13():1059725. PubMed ID: 36591229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data.
    Zhao H; Zhang S; Yin X; Zhang C; Wang L; Liu K; Xu H; Liu W; Bo L; Lin S; Feng K; Lin L; Fei M; Ning S; Wang L
    Front Immunol; 2022; 13():990143. PubMed ID: 36304471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Lipids and Lipid Metabolism in Prostate Cancer Progression and the Tumor's Immune Environment.
    Siltari A; Syvälä H; Lou YR; Gao Y; Murtola TJ
    Cancers (Basel); 2022 Sep; 14(17):. PubMed ID: 36077824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional redundancy of mitochondrial enoyl-CoA isomerases in the oxidation of unsaturated fatty acids.
    van Weeghel M; te Brinke H; van Lenthe H; Kulik W; Minkler PE; Stoll MS; Sass JO; Janssen U; Stoffel W; Schwab KO; Wanders RJ; Hoppel CL; Houten SM
    FASEB J; 2012 Oct; 26(10):4316-26. PubMed ID: 22782973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisomes and beta-oxidation of long-chain unsaturated carboxylic acids.
    Hiltunen JK
    Scand J Clin Lab Invest Suppl; 1991; 204():33-46. PubMed ID: 2042025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid oxidation enzyme Δ3, Δ2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients.
    Bramhecha YM; Guérard KP; Audet-Walsh É; Rouzbeh S; Kassem O; Pernet E; Scarlata E; Hamel L; Brimo F; Divangahi M; Aprikian AG; Chevalier S; Giguère V; Lapointe J
    Oncogene; 2022 May; 41(20):2798-2810. PubMed ID: 35411033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisomal Delta3-cis-Delta2-trans-enoyl-CoA isomerase encoded by ECI1 is required for growth of the yeast Saccharomyces cerevisiae on unsaturated fatty acids.
    Gurvitz A; Mursula AM; Firzinger A; Hamilton B; Kilpeläinen SH; Hartig A; Ruis H; Hiltunen JK; Rottensteiner H
    J Biol Chem; 1998 Nov; 273(47):31366-74. PubMed ID: 9813046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of Saccharomyces cerevisiae Delta3, Delta2-enoyl-CoA isomerase.
    Geisbrecht BV; Zhu D; Schulz K; Nau K; Morrell JC; Geraghty M; Schulz H; Erdmann R; Gould SJ
    J Biol Chem; 1998 Dec; 273(50):33184-91. PubMed ID: 9837886
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.